Secondary Particle Interactions in a Compton Camera Designed for
Compton camera
energy spectrum
proton range verification
proton therapy
secondary radiation
Journal
IEEE transactions on radiation and plasma medical sciences
ISSN: 2469-7311
Titre abrégé: IEEE Trans Radiat Plasma Med Sci
Pays: United States
ID NLM: 101705223
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
1
6
2021
Statut:
ppublish
Résumé
The purpose of this study was to determine the types, proportions, and energies of secondary particle interactions in a Compton camera (CC) during the delivery of clinical proton beams. The delivery of clinical proton pencil beams ranging from 70 to 200 MeV incident on a water phantom was simulated using Geant4 software (version 10.4). The simulation included a CC similar to the configuration of a Polaris J3 CC designed to image prompt gammas (PGs) emitted during proton beam irradiation for the purpose of
Identifiants
pubmed: 34056151
doi: 10.1109/trpms.2020.3030166
pmc: PMC8153369
mid: NIHMS1699212
doi:
Types de publication
Journal Article
Langues
eng
Pagination
383-391Subventions
Organisme : NCI NIH HHS
ID : R01 CA187416
Pays : United States
Références
Phys Med Biol. 2015 Oct 7;60(19):7617-35
pubmed: 26389549
Phys Med Biol. 2015 Sep 21;60(18):7085-99
pubmed: 26317610
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):1-3
pubmed: 27084615
Theranostics. 2013 Sep 19;3(10):731-40
pubmed: 24312147
Med Phys. 2018 Nov;45(11):e1036-e1050
pubmed: 30421803
Med Phys. 2018 May;45(5):2195-2204
pubmed: 29532490
Phys Med Biol. 2018 Sep 17;63(18):185019
pubmed: 30033938
J Radioanal Nucl Chem. 2018 Oct;318(1):241-246
pubmed: 31327884
Nat Rev Clin Oncol. 2013 Jul;10(7):411-24
pubmed: 23689752
Front Oncol. 2015 Jul 07;5:150
pubmed: 26217586
Phys Med Biol. 2012 Jun 7;57(11):3537-53
pubmed: 22588144
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):920-34
pubmed: 17544003
Phys Med Biol. 2012 Jun 7;57(11):R99-117
pubmed: 22571913
Phys Med Biol. 2013 Aug 7;58(15):R131-60
pubmed: 23863203
Radiother Oncol. 2012 Apr;103(1):8-11
pubmed: 22405807
Phys Med Biol. 2017 Aug 18;62(17):L20-L30
pubmed: 28742053
Radiother Oncol. 2016 Feb;118(2):232-7
pubmed: 26774764
Phys Med Biol. 2012 Jun 7;57(11):3371-405
pubmed: 22572603
Z Med Phys. 2019 Feb;29(1):59-65
pubmed: 29858131
Phys Med Biol. 2013 Oct 21;58(20):L37-49
pubmed: 24077338
Phys Med Biol. 2013 Sep 7;58(17):5821-31
pubmed: 23920051
Transl Cancer Res. 2012 Oct 1;1(3):184-195
pubmed: 25520941
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):268-75
pubmed: 20472369
Phys Med Biol. 2014 Oct 7;59(19):5849-71
pubmed: 25207724
Adv Drug Deliv Rev. 2017 Jan 15;109:26-44
pubmed: 27919760
Med Phys. 2017 Aug;44(8):e77-e90
pubmed: 28547820
Phys Med Biol. 2020 Jun 18;65(12):125004
pubmed: 32320971
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):210-218
pubmed: 28816148
IEEE Trans Radiat Plasma Med Sci. 2017 Jul;1(4):358-367
pubmed: 28736766
IEEE Trans Radiat Plasma Med Sci. 2020 Mar;4(2):170-183
pubmed: 32258856
Med Phys. 2018 Feb;45(2):783-793
pubmed: 29159885